These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 19100906

  • 21. Can immunosuppressive strategies be used to reduce cancer risk in renal transplant patients?
    Geissler EK.
    Transplant Proc; 2010 Nov; 42(9 Suppl):S32-5. PubMed ID: 21095449
    [Abstract] [Full Text] [Related]

  • 22. Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement.
    Lang UE, Heger J, Willbring M, Domula M, Matschke K, Tugtekin SM.
    Transplant Proc; 2009 Dec; 41(10):4285-8. PubMed ID: 20005385
    [Abstract] [Full Text] [Related]

  • 23. Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin.
    Gaumann A, Schlitt HJ, Geissler EK.
    Transpl Int; 2008 Mar; 21(3):207-17. PubMed ID: 18069922
    [Abstract] [Full Text] [Related]

  • 24. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM, Schena FP.
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW.
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evidence for immunosuppression in lung transplantation.
    Hopkins PM, McNeil K.
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [Abstract] [Full Text] [Related]

  • 34. Cancers after renal transplantation: multicenter experience.
    Harzallah K, Abderrahim E, Chareffedine K, Yeich S, Belhadj R, Skhiri H, Younsi F, Abdallah TB, Abdelletif A, Hachicha J, Hmida J, El May M, Khedr A, Manaa J.
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):825-30. PubMed ID: 18711309
    [Abstract] [Full Text] [Related]

  • 35. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A, Dunkler D, Messeritsch E, Sandor N, Heidler G, Rödler S, Ankersmit J, Zuckermann A, Tschachler E.
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [Abstract] [Full Text] [Related]

  • 36. Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.
    Demirjian S, Stephany B, Abu Romeh IS, Boumitri M, Yamani MH, Poggio ED.
    Clin Transplant; 2009 Sep; 23(3):351-60. PubMed ID: 19208105
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Nonimmunosuppressive effects of mammalian target of rapamycin inhibitors.
    Cruzado JM.
    Transplant Rev (Orlando); 2008 Jan; 22(1):73-81. PubMed ID: 18631860
    [Abstract] [Full Text] [Related]

  • 39. [Cancer after kidney transplantation].
    Sandrini S, Setti G, Bossini N, Maiorca P.
    G Ital Nefrol; 2004 Jan; 21 Suppl 26():S67-73. PubMed ID: 15732048
    [Abstract] [Full Text] [Related]

  • 40. The effect of switching from calcineurin inhibitor to sirolimus on the incidence of skin cancers in kidney transplant recipients.
    McQuillan RF, O'Seaghdha CM, Bagatto A, Manusamy M, Errakiah N, Sinnott C, O'Kelly P, Murphy GM, Conlon PJ.
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):330-1. PubMed ID: 18631208
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.